ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Neurology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,077Medicare Part D Prescriptions Filled, Including Refills

Rank: 4 out of 254

$926K Total Retail Price of All Prescriptions

Rank: 21 out of 254

769 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
95% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 769 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

4% of this provider’s 769 patients filled at least one prescription for a schedule three drug, compared to an average of 1%.

Risky Drugs to Seniors

0% of this provider’s 5,580 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

40% of this provider’s prescriptions were for brand-name drugs, compared to an average of 31%.

Prescription Price

$152 was the average price of a prescription from this provider, compared to $285 among peers.

Prescriptions per Patient

8 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
CARBIDOPA-LEVODOPA 692 668 1 1
NAMENDA 340 328 2 4
GABAPENTIN 327 297 3 2
DICLOFENAC POTASSIUM 274 259 4 67
LIDOCAINE-PRILOCAINE 273 261 5 69
AZILECT 258 234 6 21
SERTRALINE HCL 243 206 7 16
DONEPEZIL HCL 235 235 8 3
AMANTADINE 222 207 9 30
ROPINIROLE HCL 181 170 10 26
LYRICA 169 133 11 9
EXELON 155 155 12 8
TOPIRAMATE 149 118 13 6
CYMBALTA 145 125 14 14
PRIMIDONE 116 111 15 10
TRAMADOL HCL 99 94 16 41
KETOPROFEN 85 77 17 143
LEVETIRACETAM 84 71 18 5
OXCARBAZEPINE 83 71 19 19
TIZANIDINE HCL 82 76 20 34
REQUIP XL 78 78 21 112
ZOLPIDEM TARTRATE 78 78 21 38
ESCITALOPRAM OXALATE 72 70 23 24
STALEVO 100 71 71 24 84
VOLTAREN 65 59 25 92
LAMOTRIGINE 59 57 26 7
LIDODERM 57 45 27 65
PROPRANOLOL HCL 56 54 28 42
STALEVO 125 54 54 10 29 176
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.